Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.

Saved in:
Bibliographic Details
Title: Molecular Engineering of Interleukin-2 for Enhanced Therapeutic Activity in Autoimmune Diseases.
Authors: Tomasovic LM; Medical Scientist Training Program, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Liu K; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., VanDyke D; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA., Fabilane CS; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Program in Molecular Biophysics, Johns Hopkins University, Baltimore, MD, USA., Spangler JB; Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Translational Tissue Engineering Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Chemical and Biomolecular Engineering, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Bloomberg Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jamie.spangler@jhu.edu.; Department of Molecular Microbiology and Immunology, Johns Hopkins University School of Public Health, Baltimore, MD, USA. jamie.spangler@jhu.edu.
Source: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy [BioDrugs] 2024 Mar; Vol. 38 (2), pp. 227-248. Date of Electronic Publication: 2023 Nov 24.
Publication Type: Journal Article; Review
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9705305 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-190X (Electronic) Linking ISSN: 11738804 NLM ISO Abbreviation: BioDrugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1179-190X
DOI:10.1007/s40259-023-00635-0